2 The Frontier Drug INT230-6 Has Shown Promising Therapeutic Results In Soft Tissue Sarcoma! Apr 16, 2025
3 Hutchison Pharmaceuticals Announces Approval Of Cd73 Monoclonal Antibody Mupadolimab In Phase I/Ib Clinical Trial In China Feb 22, 2025
6 New Targeted Drug For Leukaemia Approved, 35% Of Patients' Cancer Cells Disappear Completely! Feb 06, 2025
Read More Medical Neratinib Included In NCCN Guidelines For Specific HER2-Negative Breast Cancers Apr 11, 2025
Read More Disease What Is The Difference Between Laryngeal Cancer And Pharyngitis? What Is The Way To Confirm The Diagnosis Of Laryngeal Cancer? Apr 15, 2025
Read More Apparatus New Lymphoma Drug Approved! Half Of The Patients Had Significant Tumour Regression Apr 09, 2025
Read More Medical Cutting-Edge Targeted Drug For Cholangiocarcinoma Significantly Extends Patients' Lives! Apr 06, 2025
Read More Apparatus Clinical Approval For Colombotide Skb264 (Mk-2870) In Combination With Oxitinib Apr 05, 2025
